最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/5/02 | 13:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
2024/5/02 | 00:49 | EDGAR2 | Form POS AM - Post-Effective amendments for registration.. |
2024/1/05 | 23:23 | GLOBE | Novartis expands production of Pluvicto™ with addition of.. |
2023/12/11 | 09:30 | GLOBE | Novartis presents new 48-week results from Phase III.. |
2023/12/08 | 23:15 | GLOBE | Latest Novartis Kisqali® NATALEE analysis reinforces 25%.. |
2023/12/06 | 09:16 | GLOBE | Novartis receives FDA approval for Fabhalta® (iptacopan),.. |
2023/11/20 | 15:15 | GLOBE | Novartis showcases significant data updates from Kisqali®,.. |
2023/10/25 | 06:01 | EDGAR2 | Form 8-K - Current report |
2023/10/21 | 06:00 | EDGAR2 | Form 8-K - Current report |
2023/9/08 | 05:58 | EDGAR2 | Form 8-K - Current report |
2023/8/25 | 05:31 | EDGAR2 | Form 8-K - Current report |
2023/7/27 | 05:50 | EDGAR2 | Form 8-K - Current report |
2023/7/18 | 05:30 | EDGAR2 | Form 8-K - Current report |
2023/7/17 | 22:23 | EDGAR2 | Form 8-K - Current report |
2023/7/17 | 21:45 | GLOBE | Novan Enters into Agreement to Sell Substantially All of its.. |
2023/7/07 | 06:00 | EDGAR2 | Form 8-K - Current report |